Septerna (SEPN) Equity Ratio (2023 - 2026)
Septerna's quarterly Equity Ratio came in at 0.66 in Q1 2026, up 172.03% year-on-year from 0.24 in Q1 2025, and up 3.7% quarter-over-quarter from 0.64 in Q4 2025.
Septerna has reported Equity Ratio for 4 years, with the latest figure at 0.66 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio rose 172.03% year-over-year to 0.66; the trailing twelve-month figure through Mar 2026 stood at 0.66 (up 172.03% YoY), and the FY2025 full-year result was 0.64, down 30.37% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.66, up from 0.64 in the prior quarter.
- The five-year high for Equity Ratio was 0.92 in Q4 2024, with the low at 0.92 in Q1 2025.
- Average Equity Ratio over 4 years is 0.26, with a median of 0.64 recorded in 2025.
- Year-over-year, Equity Ratio jumped 413.76% in 2024 and tumbled 30.37% in 2025.
- Tracing SEPN's Equity Ratio over 4 years: stood at 0.29 in 2023, then jumped by 413.76% to 0.92 in 2024, then slumped by 30.37% to 0.64 in 2025, then climbed by 3.7% to 0.66 in 2026.
- The last three Equity Ratio figures came in at 0.66 (Q1 2026), 0.64 (Q4 2025), and 0.64 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.21 |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | 0.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.66 |
| Dec 31, 2025 | 0.64 |
| Sep 30, 2025 | 0.64 |
| Jun 30, 2025 | 0.91 |
| Mar 31, 2025 | -0.92 |
| Dec 31, 2024 | 0.92 |
| Sep 30, 2024 | -0.50 |
| Dec 31, 2023 | -0.29 |